HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Renjifo, X. Articles by Moser, M. Search for Related Content PubMed PubMed Citation Articles by Renjifo, X. Articles by Moser, M.

Carrier-Induced, Hapten-Specific Suppression: A Problem of Antigen Presentation?¹

Ximena Renjifo^*, Stanley Wolf, Paul-Pierre Pastoret, Hervé Bazin^§, Jacques Urbain^*, Oberdan Leo^* and Muriel Moser^2,*

^* Département de Biologie Moléculaire, Université Libre de Bruxelles, Rhode-SaintGenèse, Belgium; Genetics Institute, Cambridge, MA 02140; Département de Virologie-Immunologie, Université de Liège, Liège, Belgium; and ^§ Unité d’Immunologie Expérimentale, Université Catholique de Louvain, Bruxelles, Belgium

Prior immunity against a carrier protein has been shown to modulate the serologic response to injected haptens attached to the same carrier. In particular, a carrier/hapten-carrier immunization protocol induces marked suppression for IgG2a anti-hapten Ab production but does not interfere with anti-carrier Ab responses. Although the phenomenon of epitopic suppression has been amply demonstrated, the mechanism underlying the suppression remains unknown. The selective deficiency in IgG2a secretion suggests that IFN--producing Th1 cells are not properly activated. We and others have shown that the nature of the APCs present during the first encounter with the Ag influences the development of selected Th populations in vivo; dendritic cells (DCs) seem to be required for the induction of primary, Th1-type responses. Since carrier priming induces the clonal expansion of specific B cells that appear to efficiently capture the Ag, we hypothesized that the hapten-carrier conjugate may be presented by B cells in preimmunized animals. Therefore, we immunized mice to the conjugate by injecting syngeneic DCs pulsed in vitro with the Ag. Our data show that an injection of DCs and IL-12 prevents epitopic suppression, suggesting that it may result from defective Ag presentation.

This article has been cited by other articles:

				K. Baraldo, E. Mori, A. Bartoloni, F. Norelli, G. Grandi, R. Rappuoli, O. Finco, and G. Del Giudice Combined Conjugate Vaccines: Enhanced Immunogenicity with the N19 Polyepitope as a Carrier Protein Infect. Immun., September 1, 2005; 73(9): 5835 - 5841. [Abstract] [Full Text] [PDF]

				S G Hannesdottir, X Han, T Lund, M Singh, R van der Zee, I M Roitt, and P J Delves Changes in the reproductive system of male mice immunized with a GnRH-analogue conjugated to mycobacterial hsp70 Reproduction, September 1, 2004; 128(3): 365 - 371. [Abstract] [Full Text] [PDF]